Clinical Trial Update: Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) [Phase 3]

View source ↗

Summary

Phase 3 trial reports on efficacy and safety of IgPro10 (intravenous immunoglobulin) for primary immunodeficiencies; study completed in agammaglobulinemia and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency
• Hypogammaglobulinemia
• X-linked Agammaglobulinemia

Drugs mentioned

• IgPro10 (intravenous immunoglobulin)

Snippet

Sponsor: CSL Behring | Conditions: Agammaglobulinemia, IgG Deficiency | Phase 3 | Status: COMPLETED